Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Clichy, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
FranceStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
FranceStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
FranceStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
FranceStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
FranceStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
FranceStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
FranceStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FranceStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis
FranceStudy of Pembrolizumab and Drug Combination for Patients with Advanced Esophageal Cancer
FranceEfficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on inflammatory bowel diseases and advanced treatment methods, including studies on Crohn's disease and ulcerative colitis using fecal microbiota transplantation as therapeutic approaches.
Research aims to improve patient outcomes through novel therapeutic interventions and treatment strategies.
Comprehensive studies on liver diseases and biliary tract conditions, investigating new treatments for cirrhosis, portal hypertension, and various forms of liver cancer.
Advanced therapeutic approaches combining immunotherapy and targeted treatments.
Groundbreaking research on pancreatic cancer and metabolic conditions, evaluating novel drug combinations and treatment protocols.
Focus on improving survival rates and treatment efficacy in advanced-stage diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
